TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)
CUSIP: 881624209
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 1,148,777,709
- Total 13F shares
- 578,768,724
- Share change
- +24,268,717
- Total reported value
- $7,127,077,578
- Put/Call ratio
- 97%
- Price per share
- $12.33
- Number of holders
- 435
- Value change
- +$321,923,360
- Number of buys
- 177
- Number of sells
- 194
Quarterly Holders Quick Answers
What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 881624209:
Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
11%
|
130,090,801
|
$1,168,200,000 | — | 31 Mar 2020 | |
| BERKSHIRE HATHAWAY INC |
13F
|
Company |
3.7%
|
42,789,295
|
$384,248,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.3%
|
37,736,307
|
$338,871,000 | — | 31 Mar 2020 | |
| Capital World Investors |
13F
|
Company |
2.9%
|
33,086,826
|
$297,114,000 | — | 31 Mar 2020 | |
| ABRAMS CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.1%
|
24,046,356
|
$215,936,000 | — | 31 Mar 2020 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
1.9%
|
21,970,954
|
$197,299,000 | — | 31 Mar 2020 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
1.4%
|
16,555,000
|
$148,664,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
1.3%
|
15,402,985
|
$138,319,000 | — | 31 Mar 2020 | |
| Capital International Investors |
13F
|
Company |
1.2%
|
13,881,896
|
$124,659,000 | — | 31 Mar 2020 | |
| Clal Insurance Enterprises Holdings Ltd |
13F
|
Company |
1.2%
|
13,313,571
|
$119,556,000 | — | 31 Mar 2020 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.99%
|
11,329,369
|
$99,306,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
0.74%
|
8,477,252
|
$76,126,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.73%
|
8,351,915
|
$75,000,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
8,017,872
|
$72,001,000 | — | 31 Mar 2020 | |
| MILLER VALUE PARTNERS, LLC |
13F
|
Company |
0.69%
|
7,918,362
|
$71,107,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.57%
|
6,578,463
|
$59,074,000 | — | 31 Mar 2020 | |
| Harel Insurance Investments & Financial Services Ltd. |
13F
|
Company |
0.57%
|
6,529,522
|
$58,635,000 | — | 31 Mar 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.53%
|
6,042,601
|
$54,263,000 | — | 31 Mar 2020 | |
| Swiss National Bank |
13F
|
Company |
0.37%
|
4,307,499
|
$38,681,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
4,285,701
|
$38,400,000 | — | 31 Mar 2020 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.37%
|
4,202,573
|
$37,739,000 | — | 31 Mar 2020 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.34%
|
3,962,483
|
$36,283,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.31%
|
3,581,556
|
$32,162,000 | — | 31 Mar 2020 | |
| Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) |
13F
|
Company |
0.31%
|
3,545,657
|
$31,840,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
3,199,032
|
$28,727,000 | — | 31 Mar 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.27%
|
3,092,700
|
$27,772,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.27%
|
3,088,887
|
$27,738,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.26%
|
2,999,085
|
$26,930,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.25%
|
2,873,290
|
$25,802,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.25%
|
2,859,028
|
$25,673,000 | — | 31 Mar 2020 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.23%
|
2,659,454
|
$23,882,000 | — | 31 Mar 2020 | |
| Noked Capital LTD |
13F
|
Company |
0.23%
|
2,595,000
|
$23,303,000 | — | 31 Mar 2020 | |
| Noked Israel Ltd |
13F
|
Company |
0.23%
|
2,595,000
|
$23,303,000 | — | 31 Mar 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.22%
|
2,473,217
|
$22,209,000 | — | 31 Mar 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.19%
|
2,225,544
|
$19,985,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.18%
|
2,058,700
|
$18,487,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.18%
|
2,034,916
|
$18,274,000 | — | 31 Mar 2020 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.18%
|
2,023,300
|
$18,169,000 | — | 31 Mar 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.17%
|
1,993,357
|
$17,900,344 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
1,891,632
|
$16,987,000 | — | 31 Mar 2020 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.16%
|
1,843,246
|
$16,552,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
1,785,232
|
$16,031,000 | — | 31 Mar 2020 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.15%
|
1,777,700
|
$15,964,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.15%
|
1,675,179
|
$15,043,000 | — | 31 Mar 2020 | |
| PGGM Investments |
13F
|
Individual |
0.14%
|
1,613,034
|
$14,485,000 | — | 31 Mar 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.14%
|
1,607,861
|
$14,439,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.14%
|
1,595,560
|
$14,329,000 | — | 31 Mar 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.14%
|
1,589,926
|
$14,278,000 | — | 31 Mar 2020 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.14%
|
1,577,561
|
$14,166,000 | — | 31 Mar 2020 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
1,500,000
|
$13,470,000 | — | 31 Mar 2020 |
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2020
As of 30 Jun 2020,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
435 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
578,768,724 shares.
The largest 10 holders included
Capital Research Global Investors, Capital World Investors, Berkshire Hathaway Inc, BlackRock Inc., ABRAMS CAPITAL MANAGEMENT, L.P., Migdal Insurance & Financial Holdings Ltd., Capital International Investors, MENORA MIVTACHIM HOLDINGS LTD., Clal Insurance Enterprises Holdings Ltd, and STATE STREET CORP.
This page lists
435
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
430
Q2 2020 holders
435
Holder diff
5
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.